GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Revenio Group Oyj (OTCPK:REVXF) » Definitions » 3-Year EPS without NRI Growth Rate

Revenio Group Oyj (Revenio Group Oyj) 3-Year EPS without NRI Growth Rate : 10.30% (As of Mar. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Revenio Group Oyj 3-Year EPS without NRI Growth Rate?

Revenio Group Oyj's EPS without NRI for the three months ended in Mar. 2024 was $0.15.

During the past 12 months, Revenio Group Oyj's average EPS without NRI Growth Rate was -13.00% per year. During the past 3 years, the average EPS without NRI Growth Rate was 10.30% per year. During the past 5 years, the average EPS without NRI Growth Rate was 20.90% per year. During the past 10 years, the average EPS without NRI Growth Rate was 20.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of Revenio Group Oyj was 55.00% per year. The lowest was -14.60% per year. And the median was 21.65% per year.


Competitive Comparison of Revenio Group Oyj's 3-Year EPS without NRI Growth Rate

For the Medical Devices subindustry, Revenio Group Oyj's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Revenio Group Oyj's 3-Year EPS without NRI Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Revenio Group Oyj's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Revenio Group Oyj's 3-Year EPS without NRI Growth Rate falls into.



Revenio Group Oyj 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.


Revenio Group Oyj  (OTCPK:REVXF) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.


Revenio Group Oyj 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Revenio Group Oyj's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Revenio Group Oyj (Revenio Group Oyj) Business Description

Traded in Other Exchanges
Address
Ayritie 22, Vantaa, FIN, 01510
Revenio Group Oyj is a Finnish health technology company. It develops and commercializes effective and easy-to-use health tech-related screening devices for the detection of diseases of significance to public health. Its ophthalmic diagnostic solutions include intraocular pressure (IOP) measurement devices (tonometers), perimeter and fundus imaging devices under the iCare brand. Its eye care software platform Oculo offers clinical communication, telehealth, remote patient monitoring, and data analytics capabilities. The company's geographical segments include Finland, Other Europe, and Others.

Revenio Group Oyj (Revenio Group Oyj) Headlines

From GuruFocus

Q4 2023 Revenio Group Oyj Earnings Call Transcript

By GuruFocus Research 02-28-2024